New treatment to help heal damaged corneas
A Novel Therapeutic to Promote Corneal Repair
['FUNDING_OTHER'] · MICROCURES, INC. · NIH-11311338
A topical eye medicine aims to speed closure and nerve regrowth after cornea injuries like chemical burns.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICROCURES, INC. (nih funded) |
| Locations | 1 site (SANTA CRUZ, UNITED STATES) |
| Trial ID | NIH-11311338 on ClinicalTrials.gov |
What this research studies
Researchers are developing a topical therapy that delivers a molecule targeting corneal cell and nerve repair to the site of injury. The approach uses a localized formulation designed to stay on the eye and slowly release the active agent to promote faster epithelial migration and reinnervation. Preclinical tests use laboratory assays and animal models to measure wound closure, tissue remodeling, and recovery of corneal sensation. If those results are favorable, the program could move toward clinical testing in people with significant corneal wounds.
Who could benefit from this research
Good fit: People with recent moderate-to-severe corneal injuries—for example large epithelial wounds or alkali/chemical burns—who need faster wound closure and nerve recovery are potential candidates.
Not a fit: Patients with minor superficial scratches, active infectious keratitis, or chronic non-injury degenerative corneal diseases may not benefit from this specific acute wound-repair therapy.
Why it matters
Potential benefit: May shorten healing time, reduce risk of ulceration or scarring, and restore corneal clarity and sensation after serious corneal injuries.
How similar studies have performed: Some topical therapies and nerve growth factor treatments have shown benefit for corneal healing, but targeting the FL2 mechanism for localized tissue remodeling is a novel approach with limited prior human data.
Where this research is happening
SANTA CRUZ, UNITED STATES
- MICROCURES, INC. — SANTA CRUZ, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KRAMER, ADAM HILDYARD — MICROCURES, INC.
- Study coordinator: KRAMER, ADAM HILDYARD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.